中文 | English
Return
Total: 196 , 1/20
Show Home Prev Next End page: GO
Author:( Xiujuan LI)

1.Construction of pcDNA3.1(+)/hFasL and its expression in COS-7 cells

Xiujuan LI

Journal of Chongqing Medical University 2003;0(06):-

2.Value of immunohistochemistry for determining the primary site of adenocarcinoma cells in pleural effusion cell block

Xiaojuan LI ; Xiujuan LI

Cancer Research and Clinic 2017;29(7):470-473

3.Recent progress in related genes of primary hyperuricemia and gout

Xiujuan ZHANG ; Changgui LI

Chinese Journal of Endocrinology and Metabolism 2011;27(7):611-613

4.On the Multidisciplinary Support and Effective Development of Hospital Pharmaceutical Care

Yuwen CHEN ; Xiujuan LI

China Pharmacy 1991;0(04):-

5.Variation of cesarean section rate and indications from 2000 to 2009 in China

Xiujuan SU ; Ting LI

Chinese Journal of Perinatal Medicine 2012;15(2):85-90

6.Construction of clinical core competence evaluation system of junior nurses by the Delphi method combined with Analytic Hierarchy Process method

Xiujuan LI ; Jing WANG ; Yuanyuan LI

Chinese Journal of Practical Nursing 2016;32(20):1583-1586

7.Construction of real-time network teaching platform in anesthesia resident standardization training

Feng JI ; Xiujuan LI ; Hui CHEN

Chinese Journal of Medical Education Research 2015;(3):316-318

8.The synergic effects of sirolimus and immature dendritic cells in prolonging survival time of skin allograft in mice

Dongmei LI ; Yong QIU ; Xiujuan HE

Chinese Journal of Organ Transplantation 2005;0(08):-

9.Clinical efficacy of cool-tip radiofrequency treatment of uterine myoma

Li YU ; Yuehua ZHENG ; Xiujuan SHAO

Chinese Journal of Primary Medicine and Pharmacy 2008;15(10):1618-1619

10.Association between the level of tumor necrosis factor ? and the clinical features of multiple sclerosis

Xiujuan SONG ; Li GUO ; Huiqing HOU

Journal of Clinical Neurology 1993;0(03):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 196 , 1/20 Show Home Prev Next End page: GO